| IPI00025803 - INSR, INSULIN RECEPTOR. | |
|---|---|
| Uniprot Accession: P06213-1 | |
| Uniprot ID: INSR_HUMAN | |
| Mapping: Chr 19, 7067049 - 7245045 | |
| Entrez Gene: 3643 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_17732) |
|---|
| Rat: Insr, TYROSINE-PROTEIN KINASE RECEPTOR. |
| Human: INSR, INSULIN RECEPTOR. |
| Human: INSR, ISOFORM SHORT OF INSULIN RECEPTOR PRECURSOR. |
| Human: INSR, INSULIN RECEPTOR ISOFORM SHORT PRECURSOR. |
| Rat: Insr, INSULIN RECEPTOR PRECURSOR. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| plasma membrane | C | ISS ISS IDA | ||
| membrane | C | IEA | ||
| cytosol | C | IDA | ||
| integral to membrane | C | IEA | IEA | |
| endosome | C | IDA | ||
| integral to plasma membrane | C | ISS | ||
| protein binding | F | ISS IPI | ||
| transmembrane receptor protein tyrosine kinase activity | F | IEA | ||
| 3-phosphoinositide-dependent protein kinase binding | F | IDA | ||
| receptor activity | F | IEA | ISS IEA | |
| insulin receptor activity | F | ISS IMP IDA IDA IMP | ||
| ATP binding | F | IEA | IEA | |
| receptor signaling protein tyrosine kinase activity | F | ISS | ||
| transmembrane receptor protein tyrosine kinase signaling protein activity | F | ISS | ||
| protein phosphatase binding | F | IMP | ||
| SH2 domain binding | F | ISS | ||
| insulin binding | F | ISS IMP IDA IMP | ||
| transferase activity | F | IEA | IEA | |
| insulin receptor substrate binding | F | ISS IMP | ||
| PTB domain binding | F | ISS | ||
| phosphoinositide 3-kinase binding | F | ISS | ||
| nucleotide binding | F | IEA | IEA | |
| protein amino acid phosphorylation | P | IEA | IDA | |
| generation of precursor metabolites and energy | P | ISS | ||
| transmembrane receptor protein tyrosine kinase signaling pathway | P | IEA | ||
| peptidyl-tyrosine phosphorylation | P | IMP | ||
| carbohydrate metabolic process | P | ISS | ||
| signal transduction | P | ISS | ||
| protein heterotetramerization | P | ISS | ||
| insulin receptor signaling pathway | P | ISS ISS IMP IDA | ||
| organ morphogenesis | P | ISS | ||
| multicellular organismal development | P | ISS | ||
| male sex determination | P | ISS | ||
| protein amino acid autophosphorylation | P | ISS IMP IDA |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| postnatal growth retardation | N | ISS | ||
| cardiac hypertrophy | N | ISS | ||
| postnatal lethality | N | ISS | ||
| increased insulin secretion | N | ISS | ||
| decreased adipose tissue amount | N | ISS | ||
| impaired glucose tolerance | N | ISS | ||
| increased circulating leptin level | N | ISS | ||
| insulin resistance | N | ISS | ||
| increased circulating insulin level | N | ISS |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| insulin signaling pathway | W | IDAIMPISS | ||
| Alzheimer disease pathway | W | IEA |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Adherens junction (04520) | Present in KEGG pathway | Not present in KEGG pathway | Present in KEGG pathway |
| Type II diabetes mellitus (04930) | Present in KEGG pathway | Not present in KEGG pathway | Present in KEGG pathway |
| Dentatorubropallidoluysian atrophy (DRPLA) (05050) | Present in KEGG pathway | Not present in KEGG pathway | Present in KEGG pathway |
| Insulin signaling pathway (04910) | Present in KEGG pathway | Not present in KEGG pathway | Present in KEGG pathway |